What is Gynoveda?
Founded in 2019 by husband-and-wife duo Rachana and Vishal Gupta, Gynoveda emerged from their desire to elevate Ayurveda as a premier choice for women's health, spanning from puberty through menopause. The company is dedicated to leveraging ancient Ayurvedic principles with modern scientific validation to address a wide spectrum of women's health concerns. This commitment positions Gynoveda as a key player in the burgeoning femtech and wellness market, aiming to provide holistic and effective solutions.
How much funding has Gynoveda raised?
Gynoveda has raised a total of $10M across 1 funding round:
Series A
$10M
Series A (2023): $10M with participation from Fireside Ventures, RPG Ventures, and India Alternatives Fund
Key Investors in Gynoveda
Fireside Ventures
Fireside Ventures is a venture capital firm specializing in health and consumer startups, aiming to build iconic brands through collaborative investment.
RPG Ventures
RPG Ventures, the corporate venture arm of RPG Enterprises, focuses on health, technology, and infrastructure, supporting early-stage ventures with synergistic potential.
India Alternatives Fund
India Alternatives Fund is an investment firm that has participated in Gynoveda's funding round, contributing to the company's growth in the women's health sector.
What's next for Gynoveda?
The recent major strategic investment signals Gynoveda's transition into a scaling phase, likely focusing on expanding its product lines, enhancing its digital platform, and broadening its market reach. This infusion of capital will be instrumental in furthering its mission to make Ayurveda a globally recognized standard for women's healthcare. Future growth may involve deeper research and development, strategic partnerships, and increased consumer education initiatives to solidify its market leadership.
See full Gynoveda company page
